SCHEMBL24812009

SCHEMBL24812009

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc(-c3cnccn3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.40
▸ MAPT P10636 6/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.39
▸ PTK2B Q14289 1/20 0.39
▸ CYP3A4 P08684 3/20 0.38
▸ LMNA P02545 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853495 0.87 TSHR (0.40) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL19275993 0.86 CYP19A1 (0.49) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL8400351 0.86 KMT2A (0.43) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL10128501 0.86 KMT2A (0.43) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL15394838 0.86 KMT2A (0.43) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL19271530 0.86 KMT2A (0.43) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL6374508 0.86 KDM4E (0.53) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL9881125 0.86 KDM4E (0.53) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL31666 0.86 KDM4E (0.53) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL8400350 0.86 KDM4E (0.53) KMT2AMAPTMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KMT2A 3009/4885MAPT 1926/4885MEN1 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback